Unternehmen Biotech Acquisition Company
Aktien
A2QPM3
KYG1125A1085
BIOT
Holdinggesellschaften
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Michael Shleifer
CEO | Chief Executive Officer | 49 | - |
Thomas Fratacci
DFI | Director of Finance/CFO | 46 | 01.09.20 |
Ivan Jarry
COO | Chief Operating Officer | 45 | 01.09.20 |
Albert F. Hummel
CIO | Chief Investment Officer | 78 | 01.09.20 |
Tanguy Serra
PRN | Corporate Officer/Principal | 45 | 03.09.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Albert F. Hummel
CIO | Chief Investment Officer | 78 | 01.09.20 |
Bruno Montanari
BRD | Director/Board Member | 49 | 25.01.21 |
Paul D. Bernard
BRD | Director/Board Member | 55 | 25.01.21 |
Michael Shleifer
CEO | Chief Executive Officer | 49 | - |
Aaron Kim
BRD | Director/Board Member | 53 | 25.01.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 5 750 000 | 0 | 0 | 80,00 % |
Aktie B | 1 | 23 000 000 | 23 000 000 ( 100,00 %) | 0 |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+173.89% | 6.65 Mrd. | |
+2.29% | 981 Mio. | |
+5.57% | 928 Mio. | |
+41.91% | 872 Mio. | |
+20.36% | 804 Mio. | |
+1.72% | 664 Mio. | |
-.--% | 600 Mio. | |
-2.15% | 593 Mio. | |
+40.25% | 552 Mio. |